Hematology

Showing

 Chronic lymphocytic leukemia (CLL)

 Gazyva® in combination with chlorambucil is indicated for the treatment of adult patients with chronic lymphocytic leukemia, who have not previously recovered from the treatment and may have a concomitant illness that makes it impossible to carry out therapy based on fludarabine at higher doses.

 Follicular lymphoma (FL)

 Gazyva® in combination with chemotherapy with further supportive therapy with the drug Gazyva®, in the available version, is indicated for the treatment of patients with previously untreated extended follicular lymphoma.

 Gazyva® in combination with bendamustine followed by supportive therapy with Gazyva® is indicated for the treatment of patients with follicular lymphoma who do not respond to treatment rituximab or combination therapy, which included rituximab, or illness progressed within an hour or over a period of 6 months after treatment with rituximab or after combination therapy, which included rituximab.

Indication

 Pomalidomide in combination with bortezomib and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior course of treatment that included lenalidomide.

 Pomalidomide in combination with dexamethasone is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have previously received at least two courses of treatment with lenalidomide and bortezomib and who have disease progression on the background of the last therapy.

Zoladex 10.8 - $180 Zoladex 3.6 - $54

$350

Imbruvica (ibrutinib) 140 mg 120 caps. Generic version. 800$

Lynparza (olaparib ) 50mg 112 caps Generic version $500 5 days delivery.

Generic Imbruvik $900 5 days for delivery.

SPTYCEL (DASATINIB) 70 MG 60 TAB GENERIC VERSION 450$